Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

Direct Payment

$75,000.00

Bioprinted tumor-on-a-chip provides an optical window into gradients of hypoxia and stiffness

EF 2016-17

Résumé
Despite great advances in understanding the cellular biology of cancer, metastases are still responsible for over 90% of the mortality in patients. State of the art in vitro models have been engineered to reproduce and study the complexity of the metastatic process. Such models allow the precise and dynamic control of structural parameters that play key roles in the clinical behavior of metastatic tumors. These parameters include soluble and physical clues from the tumor associated stroma, cellular interactions of migratory cancer cells with surrounding tissues, and physicochemical gradients that direct cell motility and invasion. This project uses stereo lithography 3D printing technique, along with human cancer cell lines, to fabricate a breast tumor construct. This construct will be integrated into a fluidic device for real-time and non-invasive monitoring of biochemical and physical factors in cancer microenvironment with organ-level complexity. As cancer therapeutics begin to shift to personalized and molecularly-targeted approaches, the predictive power of these tumor models will definitely impact the way in which the preclinical evaluation of novel drugs is conducted.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
361663
Name
Miri Ramsheh Amir Kamal
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Bioprinted tumor-on-a-chip provides an optical window into gradients of hypoxia and stiffness
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$75,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Biomaterials; Bioprinting; Cancer; Hypoxia; Organ-On-Chip
Abstract
Despite great advances in understanding the cellular biology of cancer, metastases are still responsible for over 90% of the mortality in patients. State of the art in vitro models have been engineered to reproduce and study the complexity of the metastatic process. Such models allow the precise and dynamic control of structural parameters that play key roles in the clinical behavior of metastatic tumors. These parameters include soluble and physical clues from the tumor associated stroma, cellular interactions of migratory cancer cells with surrounding tissues, and physicochemical gradients that direct cell motility and invasion. This project uses stereo lithography 3D printing technique, along with human cancer cell lines, to fabricate a breast tumor construct. This construct will be integrated into a fluidic device for real-time and non-invasive monitoring of biochemical and physical factors in cancer microenvironment with organ-level complexity. As cancer therapeutics begin to shift to personalized and molecularly-targeted approaches, the predictive power of these tumor models will definitely impact the way in which the preclinical evaluation of novel drugs is conducted.
Competitiondate
201611
Approvedterm2
1 yr 6 mths
Pinamesdelim
Miri Ramsheh, Amir Kamal
Approvedterm
1 an 6 mois
Cihrcontribution2
~ $75,000~ $0~